Regentis Biomaterials (RGNT) Retained Earnings (2024 - 2025)
Regentis Biomaterials (RGNT) posted quarterly Retained Earnings of -$55.8 million for Q4 2025, down 32.38% year-over-year from -$82.5 million in Q4 2024, and down 32.38% quarter-over-quarter from -$42.1 million in Q4 2024.
Regentis Biomaterials (RGNT) Retained Earnings (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has reported Retained Earnings for 2 consecutive years, with -$55.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings fell 32.38% year-over-year to -$55.8 million; the TTM figure through Dec 2025 stood at -$55.8 million (down 32.38% YoY), while the FY2025 annual figure was -$55.8 million, down 32.38% from the prior year.
- Retained Earnings fell to -$55.8 million in Q4 2025 per RGNT's latest filing, from -$42.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$42.1 million in Q4 2024 and bottomed at -$55.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.25 Bn | 129.03 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 52.47 Bn | 51.61 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.69 Bn | 34.34 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.67 Bn | 32.20 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 29.17 Bn | 26.49 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 25.06 Bn | 24.62 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.36 Bn | 14.95 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Regentis Biomaterials | 1.20 Mn | -6.18 Mn | - | 60.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -55.79 Mn |
| Dec 31, 2024 | -42.15 Mn |